Table 2 Clinical characteristics before and after 12 weeks of treatment with risperidone (Mean ± SD).

From: Neuroimaging markers of aberrant brain activity and treatment response in schizophrenia patients based on brain complexity

Variable

SZ0W (n = 27)

SZ12W (n = 27)

t

P value

Effect Size

PANSS-T

94.35 ± 25.16

62.70 ± 27.85

5.63

<0.001

1.09

PANSS-P

26.19 ± 7.34

15.04 ± 7.22

6.02

<0.001

1.16

PANSS-N

20.78 ± 8.61

16.63 ± 7.51

2.64

0.0140

0.51

PANSS-G

45.07 ± 13.34

29.81 ± 14.15

5.10

<0.001

0.98

  1. SZ12W vs SZ0W, paired-samples t-test. Effect size was measured by Cohen’s d.
  2. PANSS Positive and Negative Syndrome Scale, PANSS-T PANSS total scores, PANSS-P PANSS positive symptom scores, PANSS-N PANSS negative symptom scores, PANSS-G PANSS general psychopathological symptom scores.
Back to article page